Ad
related to: who makes prep hiv drug- DESCOVY® FAQs
Read More About DESCOVY®
Frequently Asked Questions
- Safety & Adherence Data
Read About DESCOVY® Efficacy,
Adherence, And Safety Data
- DESCOVY® FAQs
Search results
Results from the WOW.Com Content Network
Tablets of Truvada, a tenofovir/emtricitabine combination used for HIV pre-exposure prophylaxis. Pre-exposure prophylaxis for HIV prevention, commonly known as PrEP, is the use of antiviral drugs as a strategy for the prevention of HIV/AIDS by people that do not yet have HIV/AIDS. [1]
The abbreviation PrEP now typically refers to pre-exposure prophylaxis for HIV prevention, the use of antiviral drugs as a strategy for the prevention of HIV/AIDS. [2] PrEP is one of a number of HIV prevention strategies for people who are HIV negative but who have a higher risk of acquiring HIV, including sexually active adults at increased risk of contracting HIV, people who engage in ...
It was approved for PrEP against HIV infection in the United States in 2012. [17] The CDC recommends PrEP be considered for the following high-risk groups: [18] Individuals in an ongoing sexual relationship with an HIV-positive partner; Gay or bisexual men who either have had anal sex without a condom or been diagnosed with an STD in the past ...
GSK also said that patent protection for its best-selling antiviral ingredient dolutegravir, which is used in HIV drugs and had a combined 1.3 billion pounds in second-quarter sales, would expire ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
(Reuters) - Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 ...
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Experts say breakthrough HIV should still remain rare in those receiving ViiV Healthcare’s injectable Apretude as PrEP, an alternative to Truvada and Descovy.
Ad
related to: who makes prep hiv drug